[1] 高燕,王临英.乳腺癌化疗病人留置 PICC 真实体验的质性研究[J].全科护理,2020,18(18):2275-2277. [2] 柏兴华,臧爽.乳腺癌患者放疗期间携带经外周置入中心静脉导管真实体验的质性研究[J].中国全科医学,2014(21):2448-2451. [3] 陈巧女.乳腺癌患者拒绝 PICC 置管原因探讨[J].现代实用医学,2016,28(3):407-408. [4] YU,KE-DA,WU,SI-YU,LIU,GUANG-YU,et al.Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive,human epidermal growth factor receptor 2-negative breast cancer(CBCSG-036):A randomized,controlled,multicenter trial[J].Cancer:A Journal of the American Cancer Society,2019,125(13):2185-2193. [5] 符岸秋,郭泽霞,张秀燕.康复沙龙对乳腺癌术后留置 PICC 化疗间歇期患者生活质量的影响[J].海南医学,2017,28(24):4113-4114. [6] 孙琳琳.循证护理对乳腺癌化疗患者 PICC 置管感染发生率及留置时限的影响[J].山西卫生健康职业学院学 报,2021,31(3):123-125. [7] 王翡.老年乳腺癌病人化疗中留置 PICC 并发症的发生原因及护理对策[J].饮食保健,2018,5(45):193. [8] COLLINS,JENNIFER M.,FLEMING,GINI F.,CHRIST,TREVOR N.Comparison of the incidence of febrile neutropenia in obese and normal weight breast cancer patients receiving myelosuppressive chemotherapy and prophylactic pegfilgrastim[J].Journal of oncology pharmacy practice:official publication of the International Society of Oncology Pharmacy Practitioners,2019,25(5):1112-1118. [9] 岳芹.PICC 导管与浅静脉留置针在乳腺癌化疗中的应用比较[J].中西医结合护理(中英文),2016,2(10):81-83. [10] 顾婷婷,王娇娇.程序化健康教育结合预见性护理对乳腺癌化疗患者 PICC 导管相关并发症及自护能力的影响[J].现代养生(下半 月版),2021,21(2):58-61. [11] 高洁.手臂输液港与 PICC 在乳腺癌化疗患者中的应用探究[J].养生保健指南,2021(3):33. [12] KOMEN,MANON M.C.,VAN DEN HURK,CORINA J.G.,NORTIER,JOHAN W.R.,et al.Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia:a randomised trial in patients with breast cancer treated with adjuvant chemotherapy[J].Supportive care in cancer:official journal of the Multinational Association of Supportive Care in Cancer,2019,27(5):1919-1925. [13] 严琼玉.经外周静脉留置中心静脉导管在乳腺癌根治术后患者化疗中的应用[J].吉林医学,2016,37(8):2067-2068. [14] 张嫚,曾一,贺杰美.PICC 在乳腺癌根治术后化疗中的应用效果研究[J].实用临床护理学电子杂志,2020,5(27):135,137. [15] 王淑华,丁少冰.乳腺癌化疗患者 PICC 局部感染相关因素分析及对策[J].国际护理学杂志,2019,38(23):3869-3872.
